drugset / Trial / NCT01326312

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

NCT01326312

Phase 2 Terminated 159 enrolled GTx
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.

Timeline

Start
2011-06
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GTx-758 Small molecule 1000 mg
Subject GTx-758 Small molecule 2000 mg
Comparator Leuprolide Other / unclassified

Indications